Boilesen Astrid Elisabeth Bruun, Bisgaard Marie Luise, Bernstein Inge
The Danish HNPCC Register, Department of Gastroenterology 435, Hvidovre University Hospital, Hvidovre, Denmark.
Acta Obstet Gynecol Scand. 2008;87(11):1129-35. doi: 10.1080/00016340802443806.
Women in hereditary non-polyposis colorectal cancer (HNPCC) families have an elevated risk of endometrial and ovarian cancer. The risk in Lynch syndrome families with known mutations in mismatch repair genes (MMR genes) seems to be higher than in familial colorectal cancer (CRC) families. Data in the Danish HNPCC register on the frequency and lifetime risk of gynecologic cancers were analyzed and the actual surveillance strategy discussed in relation to the results.
Register-based retrospective study.
A total of 1,780 at-risk women were identified and epidemiological, clinical and MMR gene mutation data were retrieved.
In a total of 105 cases of endometrial cancer, there was no significant difference in MSH2, MSH6 and MLH1 mutation carrier frequency. Compared to the general population, mutation carriers had a 20 times increase in lifetime risk of endometrial cancer. Lifetime risk was elevated four times in familial CRC families. In these families, frequency was correlated to the pedigree phenotype, with significantly higher frequency demonstrated in Amsterdam II families compared to Amsterdam I families and families suspected of HNPCC. A total of 39 cases of ovarian cancer were identified with a lifetime risk of three to four times the general population. No significant correlation was found between the frequency of ovarian cancer and MMR gene mutation status in the families.
The benefit of surveillance concerning gynecological cancers seems to be less well founded in familial CRC families than in Lynch syndrome families. Modifying the surveillance strategy may be relevant in the future, but before changing existing guidelines concerning surveillance, further research is recommended.
遗传性非息肉病性结直肠癌(HNPCC)家族中的女性患子宫内膜癌和卵巢癌的风险升高。错配修复基因(MMR基因)存在已知突变的林奇综合征家族的风险似乎高于家族性结直肠癌(CRC)家族。分析丹麦HNPCC登记册中关于妇科癌症的发病率和终生风险的数据,并根据结果讨论实际的监测策略。
基于登记册的回顾性研究。
共确定了1780名有风险的女性,并检索了流行病学、临床和MMR基因突变数据。
在总共105例子宫内膜癌病例中,MSH2、MSH6和MLH1突变携带者频率无显著差异。与一般人群相比,突变携带者患子宫内膜癌的终生风险增加了20倍。家族性CRC家族的终生风险升高了4倍。在这些家族中,发病率与系谱表型相关,阿姆斯特丹II家族的发病率明显高于阿姆斯特丹I家族和疑似HNPCC的家族。共确诊39例卵巢癌,终生风险是一般人群的三到四倍。家族中卵巢癌发病率与MMR基因突变状态之间未发现显著相关性。
与林奇综合征家族相比,家族性CRC家族中妇科癌症监测的益处似乎依据不足。未来可能需要调整监测策略,但在改变现有监测指南之前,建议进一步研究。